[1]
Low, D. et al. 2019. A new side of sarcoidosis: medication and hospitalization use in a privately insured patient population. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 36, 2 (Jun. 2019), 124–129. DOI:https://doi.org/10.36141/svdld.v36i2.7206.